Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

AMRX Amneal Pharmaceuticals Inc

8,90

0,14 (1,60%)

08 Mar 2025 - Fermé

Retardé de 15 minutes

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Amneal Pharmaceuticals (NASDAQ:AMRX)
Graphique Historique de l'Action
De Fév 2025 à Mar 2025

Plus de graphiques de la Bourse Amneal Pharmaceuticals

Amneal Pharmaceuticals (NASDAQ:AMRX)
Graphique Historique de l'Action
De Mar 2024 à Mar 2025

Plus de graphiques de la Bourse Amneal Pharmaceuticals

Actualités Amneal Pharmaceuticals Inc

Form 4 - Statement of changes in beneficial ownership of securities
Vendredi 7 Mars 2025 ( il y a 2 jours) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Jeudi 6 Mars 2025 ( il y a 4 jours) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Jeudi 6 Mars 2025 ( il y a 4 jours) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Jeudi 6 Mars 2025 ( il y a 4 jours) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Jeudi 6 Mars 2025 ( il y a 4 jours) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Jeudi 6 Mars 2025 ( il y a 4 jours) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Mercredi 5 Mars 2025 ( il y a 4 jours) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Mercredi 5 Mars 2025 ( il y a 4 jours) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mercredi 5 Mars 2025 ( il y a 5 jours) • Edgar (US Regulatory)

Form 8-K - Current report
Vendredi 28 Février 2025 ( il y a 1 semaine) • Edgar (US Regulatory)

Amneal Reports Fourth Quarter and Full Year 2024 Financial Results
Vendredi 28 Février 2025 ( il y a 1 semaine) • Business Wire

Amneal Launches Mesalamine and Receives U.S. FDA Approval for Lenalidomide
Mercredi 19 Février 2025 ( il y a 3 semaines) • Business Wire

Plus d'articles sur Amneal Pharmaceuticals Inc

Db Xtrackers Ii Global S...

Fcs Flex Able Growth Plu...

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales